This powerful tool offers access to a rich set of development based performance metrics from Preclinical through Launch. The sophisticated and leading edge analysis is based on validated information and input from the world’s leading biopharma companies. Dev Metrix covers 4 key performance categories (Pipeline, Success Rates, Cycle Time, Entry) and offers users the flexibility to create custom views based on a variety of characteristics that include TA, disease, origin, molecule type and more. The peerless data set and resulting analytics makes this tool the trusted source for R&D executives throughout the world.
Most Recent Data Update: May 04, 2021
Development Metrix is one tool in the R&D Advantage Suite, benchmarks to drive portfolio performance and improve productivity